ClearPoint Neuro, Inc. (CLPT) stock
CLPTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 4/3012% above fair value
$7.71−0.15 (-1.91%)
Close on Nov 18, 2026Market cap $247.14MP/E –Yield –
ClearPoint Neuro revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
ClearPoint Neuro's revenue for the twelve months ending Sep 30, 2026 was $45.49M, up 32.5% year over year. For fiscal 2025 it was $36.97M, up 17.8% from the year before. Over ten years it grew 23.2% a year on average. The highest annual figure on record is $36.97M in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $36.97M | +17.8% |
| FY2024 | Dec 31, 2024 | $31.39M | +31.0% |
| FY2023 | Dec 31, 2023 | $23.96M | +16.6% |
| FY2022 | Dec 31, 2022 | $20.55M | +26.1% |
| FY2021 | Dec 31, 2021 | $16.30M | +27.0% |
| FY2020 | Dec 31, 2020 | $12.83M | +14.4% |
| FY2019 | Dec 31, 2019 | $11.22M | +52.5% |
| FY2018 | Dec 31, 2018 | $7.35M | -0.4% |
| FY2017 | Dec 31, 2017 | $7.38M | +28.4% |
| FY2016 | Dec 31, 2016 | $5.75M | +25.1% |
| FY2015 | Dec 31, 2015 | $4.59M | +27.5% |
| FY2014 | Dec 31, 2014 | $3.60M | -8.3% |
| FY2013 | Dec 31, 2013 | $3.93M | -22.3% |
| FY2012 | Dec 31, 2012 | $5.06M | +32.5% |
| FY2011 | Dec 31, 2011 | $3.82M | +43.0% |
| FY2010 | Dec 31, 2010 | $2.67M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $12.08M | +36.3% |
| Q2 FY2026 | Jun 30, 2026 | $10.88M | +18.1% |
| Q1 FY2026 | Mar 31, 2026 | $12.13M | +42.9% |
| Q4 FY2025 | Dec 31, 2025 | $10.41M | +34.0% |
| Q3 FY2025 | Sep 30, 2025 | $8.86M | +9.1% |
| Q2 FY2025 | Jun 30, 2025 | $9.22M | +17.3% |
| Q1 FY2025 | Mar 31, 2025 | $8.49M | +11.1% |
| Q4 FY2024 | Dec 31, 2024 | $7.77M | +14.1% |
| Q3 FY2024 | Sep 30, 2024 | $8.12M | +41.0% |
| Q2 FY2024 | Jun 30, 2024 | $7.86M | +32.1% |
| Q1 FY2024 | Mar 31, 2024 | $7.64M | +40.6% |
| Q4 FY2023 | Dec 31, 2023 | $6.81M | +31.6% |
| Q3 FY2023 | Sep 30, 2023 | $5.76M | +12.0% |
| Q2 FY2023 | Jun 30, 2023 | $5.95M | +14.4% |
| Q1 FY2023 | Mar 31, 2023 | $5.43M | +8.0% |
| Q4 FY2022 | Dec 31, 2022 | $5.17M | +20.8% |
| Q3 FY2022 | Sep 30, 2022 | $5.15M | +12.5% |
| Q2 FY2022 | Jun 30, 2022 | $5.20M | +52.4% |
| Q1 FY2022 | Mar 31, 2022 | $5.03M | +24.8% |
| Q4 FY2021 | Dec 31, 2021 | $4.28M | +15.2% |
| Q3 FY2021 | Sep 30, 2021 | $4.57M | +30.0% |
| Q2 FY2021 | Jun 30, 2021 | $3.41M | +37.7% |
| Q1 FY2021 | Mar 31, 2021 | $4.03M | +29.3% |
| Q4 FY2020 | Dec 31, 2020 | $3.72M | +15.7% |
| Q3 FY2020 | Sep 30, 2020 | $3.52M | +20.2% |
| Q2 FY2020 | Jun 30, 2020 | $2.48M | -4.9% |
| Q1 FY2020 | Mar 31, 2020 | $3.12M | +26.0% |
| Q4 FY2019 | Dec 31, 2019 | $3.21M | +41.0% |
| Q3 FY2019 | Sep 30, 2019 | $2.93M | +62.0% |
| Q2 FY2019 | Jun 30, 2019 | $2.61M | +58.3% |
| Q1 FY2019 | Mar 31, 2019 | $2.47M | +52.3% |
| Q4 FY2018 | Dec 31, 2018 | $2.28M | +35.6% |
| Q3 FY2018 | Sep 30, 2018 | $1.81M | +5.2% |
| Q2 FY2018 | Jun 30, 2018 | $1.65M | -16.7% |
| Q1 FY2018 | Mar 31, 2018 | $1.62M | -19.1% |
| Q4 FY2017 | Dec 31, 2017 | $1.68M | +2.7% |
| Q3 FY2017 | Sep 30, 2017 | $1.72M | – |
| Q2 FY2017 | Jun 30, 2017 | $1.98M | – |
| Q1 FY2017 | Mar 31, 2017 | $2.01M | – |
| Q4 FY2016 | Dec 31, 2016 | $1.64M | – |
See a number that looks wrong?